Stay updated on Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.

Latest updates to the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a site version update. The visible study information remains the same, with no changes to the study details on the page.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedFDA-regulated drug and device indicators were added to the study record, along with an expanded set of MeSH terms and updated metadata such as study dates and enrollment. The previous error-page content was removed, and the page now displays the standard ClinicalTrials.gov study details for this trial.SummaryDifference43%

- Check32 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a backend or formatting update to the ClinicalTrials.gov page rather than a substantive change to the study content.SummaryDifference16%

- Check46 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a software update. No study details or content appear to be affected.SummaryDifference0.1%

- Check67 days agoChange DetectedPage revision tag updated from v3.6.2 to v3.6.3, signaling a new build of the ClinicalTrials.gov page. This update does not appear to alter the study details or user-facing content.SummaryDifference0.1%

- Check75 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2, signaling a minor update to the page or its underlying system rather than a change to the study details.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.